Literature DB >> 19473296

Human Hendra virus infection causes acute and relapsing encephalitis.

K T Wong1, T Robertson, B B Ong, J W Chong, K C Yaiw, L F Wang, A J Ansford, A Tannenberg.   

Abstract

AIM: To study the pathology of two cases of human Hendra virus infection, one with no clinical encephalitis and one with relapsing encephalitis.
METHODS: Autopsy tissues were investigated by light microscopy, immunohistochemistry and in situ hybridization.
RESULTS: In the patient with acute pulmonary syndrome but not clinical acute encephalitis, vasculitis was found in the brain, lung, heart and kidney. Occasionally, viral antigens were demonstrated in vascular walls but multinucleated endothelial syncytia were absent. In the lung, there was severe inflammation, necrosis and viral antigens in type II pneumocytes and macrophages. The rare kidney glomerulus showed inflammation and viral antigens in capillary walls and podocytes. Discrete necrotic/vacuolar plaques in the brain parenchyma were associated with antigens and viral RNA. Brain inflammation was mild although CD68(+) microglia/macrophages were significantly increased. Cytoplasmic viral inclusions and antigens and viral RNA in neurones and ependyma suggested viral replication. In the case of relapsing encephalitis, there was severe widespread meningoencephalitis characterized by neuronal loss, macrophages and other inflammatory cells, reactive blood vessels and perivascular cuffing. Antigens and viral RNA were mainly found in neurones. Vasculitis was absent in all the tissues examined.
CONCLUSIONS: The case of acute Hendra virus infection demonstrated evidence of systemic infection and acute encephalitis. The case of relapsing Hendra virus encephalitis showed no signs of extraneural infection but in the brain, extensive inflammation and infected neurones were observed. Hendra virus can cause acute and relapsing encephalitis and the findings suggest that the pathology and pathogenesis are similar to Nipah virus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19473296     DOI: 10.1111/j.1365-2990.2008.00991.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  40 in total

1.  A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Authors:  Katharine N Bossart; Barry Rockx; Friederike Feldmann; Doug Brining; Dana Scott; Rachel LaCasse; Joan B Geisbert; Yan-Ru Feng; Yee-Peng Chan; Andrew C Hickey; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

Review 2.  Changing resource landscapes and spillover of henipaviruses.

Authors:  Maureen K Kessler; Daniel J Becker; Alison J Peel; Nathan V Justice; Tamika Lunn; Daniel E Crowley; Devin N Jones; Peggy Eby; Cecilia A Sánchez; Raina K Plowright
Journal:  Ann N Y Acad Sci       Date:  2018-08-23       Impact factor: 5.691

Review 3.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

4.  Viral pathogenesis: Unlocking Ebola persistence.

Authors:  Trina Racine; Gary P Kobinger
Journal:  Nat Microbiol       Date:  2017-08-24       Impact factor: 17.745

5.  RIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes.

Authors:  Samantha R Furr; Megan Moerdyk-Schauwecker; Valery Z Grdzelishvili; Ian Marriott
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

Review 6.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

Review 7.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

8.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

9.  A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Yan-Ru Feng; Karla A Fenton; Katharine N Bossart; Lianying Yan; Yee-Peng Chan; Christopher C Broder; Thomas W Geisbert
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Authors:  Thomas W Geisbert; Chad E Mire; Joan B Geisbert; Yee-Peng Chan; Krystle N Agans; Friederike Feldmann; Karla A Fenton; Zhongyu Zhu; Dimiter S Dimitrov; Dana P Scott; Katharine N Bossart; Heinz Feldmann; Christopher C Broder
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.